Sign in

CIK 0000948320

  • Accelerated filer

LifeMD, Inc.

Sign in to watch
Ticker
LFMD
Exchange
Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760238453
Phone
+1 866-351-5907
Business address
236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
Former names
CONVERSION LABS, INC., Immudyne, Inc.

Securities

  • LFMD Common Stock Nasdaq
  • LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
  1. 4 Grant or award Chief Acquisition Officer acquired 150,000 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 125,000 shares (grant or award)
  3. 4 Grant or award Director acquired 75,000 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award General Counsel & CCO acquired 150,000 shares (grant or award)
  6. 4 Grant or award Director acquired 225,000 shares (grant or award)
  7. 4 Grant or award Director acquired 225,000 shares (grant or award)
  8. 4 Grant or award COO acquired 150,000 shares (grant or award)
  9. 4 Open-market buy Director bought 3,945 shares at $2.94 ($11,580)
  10. 4 Open-market buy Chief Acquisition Officer bought 10,712 shares at $2.92 ($31,279)
  11. 4 Open-market buy Director bought 68,865 shares at an average $2.48 ($170,480)
  12. 4 Open-market buy General Counsel & CCO bought 11,500 shares at $2.60 ($29,900)
  13. 4 Open-market buy Director bought 139,500 shares at an average $2.18 ($303,878)
  14. 4/A Open-market buy Chief Innovation Officer bought 4,608 shares at $2.17 ($9,999)
  15. 4 Open-market buy Chief Operating Officer bought 30,000 shares at $2.19 ($65,706)
  16. 4 Open-market buy CEO bought 50,000 shares at an average $2.09 ($104,625)
  17. 4 Open-market buy Chief Innovation Officer bought 10,000 shares at $2.17 ($21,700)
  18. 4 Grant or award Director acquired 75,000 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 5 Insider Annual Insider Trading Report

Page 5 of 12 · 230 filings